about
Influenza virus hemagglutinin stalk-based antibodies and vaccinesStudying the immune response to human viral infections using zebrafishAn AGM model for changes in complement during pregnancy: neutralization of influenza virus by serum is diminished in late third trimesterPost-pandemic seroprevalence of human influenza viruses in domestic catsPredicting Hemagglutinin MHC-II Ligand Analogues in Anti-TNFα Biologics: Implications for Immunogenicity of Pharmaceutical ProteinsThe Possible Impact of Vaccination for Seasonal Influenza on Emergence of Pandemic Influenza via Reassortment.Age-specific mortality during the 1918 influenza pandemic: unravelling the mystery of high young adult mortalityNeutralizing antibodies against previously encountered influenza virus strains increase over time: a longitudinal analysis.Risk assessment of H2N2 influenza viruses from the avian reservoirAssessment of influenza virus hemagglutinin stalk-based immunity in ferrets.Playing hide and seek: how glycosylation of the influenza virus hemagglutinin can modulate the immune response to infection.Immunologic characterization of a rhesus macaque H1N1 challenge model for candidate influenza virus vaccine assessment.Emerging influenza viruses and the prospect of a universal influenza virus vaccine.Refining the approach to vaccines against influenza A viruses with pandemic potential.Potent protection against H5N1 and H7N9 influenza via childhood hemagglutinin imprintingEvaluation of multivalent H2 influenza pandemic vaccines in mice.The 2008-2009 H1N1 influenza virus exhibits reduced susceptibility to antibody inhibition: Implications for the prevalence of oseltamivir resistant variant viruses.Hemagglutinin stalk antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal H1N1 viruses.Seasonal trivalent inactivated influenza vaccine protects against 1918 Spanish influenza virus infection in ferrets.Hemagglutinin Stalk-Reactive Antibodies Are Boosted following Sequential Infection with Seasonal and Pandemic H1N1 Influenza Virus in Mice.1976 and 2009 H1N1 influenza virus vaccines boost anti-hemagglutinin stalk antibodies in humansPolar residues and their positional context dictate the transmembrane domain interactions of influenza A neuraminidases.Impact of influenza A(H1N1)pdm09 virus on circulation dynamics of seasonal influenza strains in Kenya.Infection with 2009 H1N1 influenza virus primes for immunological memory in human nose-associated lymphoid tissue, offering cross-reactive immunity to H1N1 and avian H5N1 viruses.B cell response and hemagglutinin stalk-reactive antibody production in different age cohorts following 2009 H1N1 influenza virus vaccinationInfluenza mortality in the United States, 2009 pandemic: burden, timing and age distribution.In the shadow of hemagglutinin: a growing interest in influenza viral neuraminidase and its role as a vaccine antigen.Competition between influenza A virus subtypes through heterosubtypic immunity modulates re-infection and antibody dynamics in the mallard duckSimplified large-scale Sanger genome sequencing for influenza A/H3N2 virus.A pan-H1 anti-hemagglutinin monoclonal antibody with potent broad-spectrum efficacy in vivoSequential Infection in Ferrets with Antigenically Distinct Seasonal H1N1 Influenza Viruses Boosts Hemagglutinin Stalk-Specific Antibodies.H3N2 influenza virus infection induces broadly reactive hemagglutinin stalk antibodies in humans and mice.Random yet deterministic: convergent immunoglobulin responses to influenza.Human antibody responses to avian influenza A(H7N9) virus, 2013.Cross reactivity of serum antibody responses elicited by DNA vaccines expressing HA antigens from H1N1 subtype influenza vaccines in the past 30 years.Exploration of risk factors contributing to the presence of influenza A virus in swine at agricultural fairs.Comparison of Luminex NxTAG Respiratory Pathogen Panel and xTAG Respiratory Viral Panel FAST Version 2 for the Detection of Respiratory VirusesFlow cytometry reveals that H5N1 vaccination elicits cross-reactive stem-directed antibodies from multiple Ig heavy-chain lineages.Human Rhinovirus Diversity and Evolution: How Strange the Change from Major to Minor.Heads, stalks and everything else: how can antibodies eradicate influenza as a human disease?
P2860
Q27001190-D78D401A-A80B-46BC-AD2B-BC9F499DB3C3Q27002635-CE19E1EE-4F7A-4CB8-A955-936AEA039DEAQ27326934-21707A13-6333-48D9-A681-47B049840326Q28356486-5862C33B-1BD4-47CE-A376-D21621133FBAQ28547255-7BCBCD78-53AC-42D1-9334-C9D596AA92C0Q30205724-F5F2F1B3-78B6-4538-AC52-947854BB75C2Q30352787-88541338-DB58-4CBB-8E2C-3F1A12E96543Q30352862-E37672DD-E7EC-407D-8A23-06142D4D3BC5Q30355580-378CCBB5-5601-4FE6-89D3-16CC3EE6E282Q30357665-103237C1-8E92-4061-A456-875B7580531BQ30360290-76C54AB4-2679-47DF-936D-BC8FD1AC1E9DQ30367637-F5BB91DF-DE05-467B-815D-BBC929C5D1EEQ30372274-374B3D06-5499-4B6E-8893-2305D3E020B8Q30381595-2E26C948-AFD4-4722-9370-FA50EE9BD782Q30395224-54507FD8-ABC2-457E-A7DF-7E77162E2C00Q30398507-93DC6B31-433A-481B-9640-CB09F2DB15D4Q30410229-27117A80-E33A-43E0-95E9-D00611A2B1A8Q30412616-C2F8FA37-CBEC-4E6D-99B0-479753932A73Q30416288-0ECD53C8-CE5D-431A-B6A3-06D17D226C32Q30419085-310FF608-760E-4D2F-B020-D407A795E266Q30422641-50622DD6-7238-442C-AE1E-9A19223447F9Q30427691-43A017E6-DA88-4CBC-84C6-EDA5F4979C14Q30427802-2D76D2B0-2ABF-4D86-9FF7-62CBF9679679Q30427946-A188C111-74C3-41AE-8FB7-9C1AFDEC8CAEQ30429248-965A652E-8CEF-4C84-8BFE-E52A32B5641BQ30431184-2532A74E-0C7E-44F3-880F-F6792F335190Q33820732-A46A2D2D-B3E6-42C1-A967-5F502FFEB902Q33825695-DA9BCD8C-081E-43E0-83A5-4390457FEE69Q34760835-BB8910DB-45F1-453B-BF1D-70BD692EEBE5Q36023093-E678EBC9-F28A-4548-BB87-D52D44A59706Q36434265-B1BB06F2-93F6-4BF6-A109-7236B99F53E1Q36760064-BAC81A5C-C77F-4DC5-A332-B68519961A46Q37126518-10A91F86-18C7-48DA-9E69-FE05F10BF433Q37513498-A861EC3C-88F7-4421-B7F3-4B5C77AE6C49Q37530450-F8AC5987-03F6-4533-B771-DB14692FC5EAQ37554823-5FC8022A-53F7-47E7-9090-1401B8CA35F8Q37683005-48C1A2EC-BD40-4C61-87C3-637618BEEF41Q37713881-5BFDBBCA-8902-4BB3-A6B7-BE657C390755Q38768816-4E2939BB-C85A-44DD-BE44-0D0577FDB720Q38804059-BD0F0655-89E8-4F97-A98C-957EE2F9B3B6
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Why do influenza virus subtypes die out? A hypothesis.
@ast
Why do influenza virus subtypes die out? A hypothesis.
@en
type
label
Why do influenza virus subtypes die out? A hypothesis.
@ast
Why do influenza virus subtypes die out? A hypothesis.
@en
prefLabel
Why do influenza virus subtypes die out? A hypothesis.
@ast
Why do influenza virus subtypes die out? A hypothesis.
@en
P2860
P921
P356
P1433
P1476
Why do influenza virus subtypes die out? A hypothesis.
@en
P2093
Taia T Wang
P2860
P356
10.1128/MBIO.00150-11
P50
P5008
P577
2011-08-30T00:00:00Z